Charles River Labs, William Blair

Riverwater Partners, an investment management company, released its “Sustainable Value Strategy” Q4 2024 investor letter. A ...
Analysts have recently evaluated Charles River and provided 12-month price targets. The average target is $214.5, accompanied by a high estimate of $250.00 and a low estimate of $185.00. A 2.72% drop ...
Charles River Laboratories (CRL) stock as the company expects a revenue decline in 2025 due to headwinds in its DSA and CDMO ...
Mizuho Securities analyst Ann Hynes has maintained their neutral stance on CRL stock, giving a Hold rating yesterday.Stay Ahead of the ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
First Hawaiian Bank lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) ...
Apollo for Biologics: Provides a centralized platform to submit sample submission forms, track samples, and exchange documents all in one place, ensuring accuracy and saving time.
The integration enables closed system processing, a significant step in automating platforms and protocols for cell therapies ...